What Was 2024’s Top Story?

Top stories in 2024 included major developments in abortion and bird flu, the killing of UnitedHealthcare’s CEO, the selection of Robert F. Kennedy Jr. to lead HHS, new indications for GLP-1 drugs, and more.

Ian Ingram is Managing Editor at MedPage Today and helps cover oncology for the site.

Power Secures $11.9M to Democratize Clinical Trials

What You Should Know: – Power, the company transforming the traditional clinical trial landscape, announced today the close of their $11.9M Series A funding round

February 22, 2024

Novel Cardiac Myosin Inhibitor Improves Exercise Capacity in HCM

The novel cardiac myosin inhibitor aficamten improved peak oxygen uptake in symptomatic obstructive hypertrophic cardiomyopathy (HCM), the pivotal SEQUOIA-HCM trial showed. At 24 weeks, the

May 14, 2024

Everolimus by Novartis for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.